MBX vs META · $1.98B cap vs P/E 29, rev $60.80B
MBX Biosciences, Inc. Common Stock (MBX) versus Meta Platforms Inc. (META) — a side-by-side from cached financials, not a winner call.
MBX Biosciences, Inc. Common Stock (MBX) is a biotechnology company listed on NASDAQ.
Meta Platforms Inc. (META) is a internet content & information company listed on US. It is led by Mark Zuckerberg.
MBX does not have a complete income-statement cache yet.
Latest reported META revenue for 2026-06-30 was $60.80B. Net income was $15.85B. Revenue was up 8.0% from 2026-03-31 to 2026-06-30. META currently screens at market cap $1.64T and trailing P/E 28.8.
MBX currently screens at market cap $1.98B. META currently screens at market cap $1.64T and trailing P/E 28.8.
Not investment advice. Open the MBX and META stock pages for the full models.
Not investment advice.